AIDS Drug Assistance Program (ADAP) Emergency Relief Funds (ERF)

The AIDS Drug Assistance Program Emergency Relief Funds are designed to provide federal financial support to states and territories to eliminate or reduce waiting lists for life-saving antiretroviral medications and to address other critical gaps in the ADAP system. This funding aims to ensure uninterrupted access to HIV/AIDS medications for low-income individuals who rely on the program, thereby strengthening the public health response to HIV across the United States. The initiative targets immediate and urgent needs where program shortfalls threaten patient outcomes and public health objectives. The funding opportunity is administered by the Health Resources and Services Administration under the Department of Health and Human Services and was posted for awareness on July 13, 2026. While no solicitation number or NAICS code is listed, the program is forecasted as a federal grant opportunity with no specified set-aside for particular entities. All performance is expected to occur within U.S. jurisdictions, and inquiries should be directed to Glenn Clark at the provided contact information. Entities interested in applying should monitor the Grants.gov portal for the official notice and application instructions.